A recent abstract published in Nature Communications outlines a new, easy-to-use tool that could help guide early treatment discussions for people with mHSPC. In a nutshell, the innovative system ...
A polygenic risk score was able to detect a high proportion of clinically significant prostate cancer. Cancer would not have been detected in 71.8% of patients with the use of PSA or MRI screening.
Researchers are developing genomic screening tools to tailor radiation dose and hormone therapy for prostate cancer patients, ...
Please provide your email address to receive an email when new articles are posted on . A new model showed greater accuracy at predicting prostate cancer mortality vs. existing tools. It incorporates ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that new data presented at the 2025 ASCO Genitourinary Cancers ...
Prostate cancer is the most common form of cancer among men in Western countries. The disease is naturally linked to aging. Professor Tone Frost Bathen at NTNU leads a number of research projects on ...
Morning Overview on MSN
New prostate cancer cell atlas may aid earlier detection, researchers say
A team of researchers has constructed the most detailed single-cell map of the adult human prostate to date, cataloging more ...
SALT LAKE CITY, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc (MYGN). (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that its Prolaris prostate cancer ...
Asianet Newsable on MSN
Prostate cancer: 6 early warning signs your body may be showing you to watch closely
Prostate cancer is a type of cancer that affects men. It used to be common only in men over 60, but that's changing. Doctors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results